13F HOLDINGS REPORT
Velan Capital Investment Management LP
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001848809-25-000001
Total Value
$115.9M
Positions
47
Other Managers
0
Confidential Omitted
No
Holdings (47)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | JASPER THERAPEUTICS INC | JSPRW | 1,188,500 | $25.4M | 21.93% |
| 2 | PRAXIS PRECISION MEDICINES I | PRAX | 300,000 | $23.1M | 19.92% |
| 3 | HERON THERAPEUTICS INC | HRTX | 6,986,744 | $10.7M | 9.22% |
| 4 | PROTARA THERAPEUTICS INC | TARA | 1,579,000 | $8.3M | 7.19% |
| 5 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 185,520 | $6.7M | 5.78% |
| 6 | TOURMALINE BIO INC | 89157D105 | 319,080 | $6.5M | 5.58% |
| 7 | JASPER THERAPEUTICS INC | JSPRW | 245,328 | $5.2M | 4.53% |
| 8 | REZOLUTE INC | RZLT | 800,000 | $3.9M | 3.38% |
| 9 | LIQUIDIA CORPORATION | LQDA | 300,000 | $3.5M | 3.04% |
| 10 | ZEVRA THERAPEUTICS INC | ZVRA | 300,000 | $2.5M | 2.16% |
| 11 | INSPIREMD INC | NSPR | 904,029 | $2.4M | 2.05% |
| 12 | VERONA PHARMA PLC | 925050106 | 50,000 | $2.3M | 2.00% |
| 13 | REPLIMUNE GROUP INC | REPL | 181,367 | $2.2M | 1.90% |
| 14 | TOURMALINE BIO INC | 89157D105 | 104,715 | $2.1M | 1.83% |
| 15 | NURIX THERAPEUTICS INC | NRIX | 97,889 | $1.8M | 1.59% |
| 16 | PERSPECTIVE THERAPEUTICS INC | CATX | 500,000 | $1.6M | 1.38% |
| 17 | ELEDON PHARMACEUTICALS INC | ELDN | 323,973 | $1.3M | 1.15% |
| 18 | KURA ONCOLOGY INC | KURA | 150,000 | $1.3M | 1.13% |
| 19 | COLLEGIUM PHARMACEUTICAL INC | COLL | 28,685 | $821,825 | 0.71% |
| 20 | AVALO THERAPEUTICS INC | AVTX | 109,972 | $817,092 | 0.71% |
| 21 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 56,700 | $669,060 | 0.58% |
| 22 | TENAX THERAPEUTICS INC | TENX | 83,333 | $515,831 | 0.45% |
| 23 | KIORA PHARMACEUTICALS INC | KPHMW | 122,223 | $403,336 | 0.35% |
| 24 | GERON CORP | GERN | 49,000 | $173,460 | 0.15% |
| 25 | WAVE LIFE SCIENCES LTD | WVE | 13,000 | $160,810 | 0.14% |
| 26 | REGULUS THERAPEUTICS INC | 75915K309 | 70,000 | $110,600 | 0.10% |
| 27 | PROQR THRAPEUTICS N V | N71542109 | 40,500 | $107,325 | 0.09% |
| 28 | ALECTOR INC | ALEC | 55,000 | $103,950 | 0.09% |
| 29 | CONTEXT THERAPEUTICS INC | CNTX | 90,000 | $94,500 | 0.08% |
| 30 | TERNS PHARMACEUTICALS INC | TERN | 17,000 | $94,180 | 0.08% |
| 31 | VENTYX BIOSCIENCES INC | 92332V107 | 35,000 | $76,650 | 0.07% |
| 32 | ENANTA PHARMACEUTICALS INC | ENTA | 13,000 | $74,750 | 0.06% |
| 33 | LARIMAR THERAPEUTICS INC | LRMR | 18,000 | $69,660 | 0.06% |
| 34 | GOSSAMER BIO INC | GOSS | 75,000 | $67,845 | 0.06% |
| 35 | ACLARIS THERAPEUTICS INC | ACRS | 27,000 | $66,960 | 0.06% |
| 36 | OVID THERAPEUTICS INC | OVID | 70,000 | $65,359 | 0.06% |
| 37 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 10,000 | $55,700 | 0.05% |
| 38 | SUTRO BIOPHARMA INC | STRO | 30,000 | $55,200 | 0.05% |
| 39 | PMV PHARMACEUTICALS INC | PMVP | 35,000 | $52,850 | 0.05% |
| 40 | FIBROGEN INC | 31572Q808 | 80,000 | $42,360 | 0.04% |
| 41 | CYTOMX THERAPEUTICS INC | CTMX | 35,000 | $36,050 | 0.03% |
| 42 | KRONOS BIO INC | 50107A104 | 35,000 | $33,250 | 0.03% |
| 43 | KARYOPHARM THERAPEUTICS INC | KPTI | 40,000 | $27,052 | 0.02% |
| 44 | BOLT BIOTHERAPEUTICS INC | BOLT | 50,000 | $26,755 | 0.02% |
| 45 | ELEVATION ONCOLOGY INC | 28623U101 | 45,000 | $25,317 | 0.02% |
| 46 | COCRYSTAL PHARMA INC | COCP | 10,000 | $20,200 | 0.02% |
| 47 | NEXTCURE INC | NXTC | 25,000 | $19,275 | 0.02% |